Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lysophosphatidic acid exerts protective effects on HEI-OC1 cells against cytotoxicity of cisplatin by decreasing apoptosis, excessive autophagy, and accumulation of ROS. | Cell Death Discov | 2023 | 37968255 | PubTator, text mining | PubMed |
| Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder. | Int J Mol Sci | 2023 | 37958570 | PubTator, text mining | PubMed |
| Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis. | ACS Omega | 2023 | 37929144 | PubTator, text mining | PubMed |
| ADRB2 inhibition combined with antioxidant treatment alleviates lung fibrosis by attenuating TGFβ/SMAD signaling in lung fibroblasts. | Cell Death Discov | 2023 | 37923730 | PubTator, text mining | PubMed |
| Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis. | Drugs | 2023 | 37882943 | PubTator, text mining | PubMed |
| Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis. | J Inflamm Res | 2023 | 37868834 | PubTator, text mining | PubMed |
| The dimerized pentraxin-like domain of the adhesion G protein-coupled receptor 112 (ADGRG4) suggests function in sensing mechanical forces. | J Biol Chem | 2023 | 37863265 | PubTator, text mining | PubMed |
| Integration of an LPAR1 Antagonist into Liposomes Enhances Their Internalization and Tumor Accumulation in an Animal Model of Human Metastatic Breast Cancer. | Mol Pharm | 2023 | 37844135 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| Expression of plasma exosomal circLPAR1 in patients with gastric cancer and its clinical application value. | Am J Cancer Res | 2023 | 37818058 | PubTator, text mining | PubMed |
| The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors. | Int J Biol Sci | 2023 | 37781524 | PubTator, text mining | PubMed |
| Dual role of autotaxin as novel biomarker and therapeutic target in pancreatic neuroendocrine neoplasms. | Cancer Sci | 2023 | 37770812 | PubTator, text mining | PubMed |
| Differential targeting of lysophosphatidic acid LPA1, LPA2, and LPA3 receptor signalling by tricyclic and tetracyclic antidepressants. | Eur J Pharmacol | 2023 | 37758013 | PubTator, text mining | PubMed |
| LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration. | Cell Commun Signal | 2023 | 37749552 | PubTator, text mining | PubMed |
| Emerging principles of primary cilia dynamics in controlling tissue organization and function. | EMBO J | 2023 | 37743763 | PubTator, text mining | PubMed |
| Social avoidance and altered hypothalamic-pituitary-adrenal axis in a mouse model of anxious depression: The role of LPA1 receptor. | Behav Brain Res | 2023 | 37741054 | PubTator, text mining | PubMed |
| Pro-phagocytic function and structural basis of GPR84 signaling. | Nat Commun | 2023 | 37709767 | PubTator, text mining | PubMed |
| An abnormal LPA/LPAR1-NHE1 axis leads to the autophagy deficiency of trophoblast cells in recurrent spontaneous abortion. | Reproduction | 2023 | 37699083 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Signalling Regulates Human Sperm Viability via the Phosphoinositide 3-Kinase/AKT Pathway. | Cells | 2023 | 37681929 | PubTator, text mining | PubMed |
| Inhibition of LPA-LPAR1 and VEGF-VEGFR2 Signaling in IPF Treatment. | Drug Des Devel Ther | 2023 | 37680863 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=9